News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Heparinex LLC Receives $1.6 Million EDGE Award to Enable Chemistry, Manufacturing and Controls for its Proprietary Heparosan Drug Delivery Technology


11/28/2011 10:24:22 AM

OKLAHOMA CITY & AUSTIN, Texas--(BUSINESS WIRE)--Heparinex, L.L.C., a biopharmaceutical company with patented drug delivery technology platforms, announced the Company has received a $1.6 million fund endowment from the Economic Development Generating Excellence program (EDGE). Heparinex and the University of Oklahoma Health Sciences Center have discovered a drug delivery technology that utilizes sugar-polymers to more safely and effectively deliver drugs used in the treatment of a number of diseases.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES